Port Capital’s Medtronic MDT Stock Holding History

Port Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,918	Closed	-$208K	–	110
2019 Q3	$208K	Buy	+1,918	New	+$200K	0.02%	114
2018 Q4	–	Sell	-2,920	Closed	-$287K	–	142
2018 Q3	$287K	Hold	2,920	–	–	0.03%	133
2018 Q2	$250K	Buy	2,920 +300	+11%	+$25.1K	0.03%	131
2018 Q1	$210K	Hold	2,620	–	–	0.03%	145
2017 Q4	$212K	Buy	+2,620	New	+$210K	0.03%	147

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Port Capital's MDT Position: Q4 2019 in Review

Port Capital sold out of Medtronic (MDT) in Q4 2019, closing a stake of 1,918 shares — an estimated $208K sold.

Port Capital first reported a position in MDT in Q4 2017 and held it in 5 quarters. The position peaked at $287K in Q3 2018. 1,820 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

Port Capital reported no remaining Medtronic position as of Q4 2019 after selling out during the quarter.
Port Capital sold 1,918 Medtronic shares in Q4 2019, an estimated $208K.
Port Capital first reported a position in Medtronic in Q4 2017 and held it in 5 quarters.
Port Capital's Medtronic position peaked at $287K in Q3 2018.
1,820 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Port Capital's 13F filing for Q4 2019, filed 14 Feb 2020.